Allen Institute invests $400M to transform brain mapping into disease treatment

The Allen Institute is launching a $400 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has

Related Stories

Jedify raises $24M to give enterprise AI agents the business context they lack

Zscaler unveils ZAgent Framework to automate zero-trust SASE operations

Exclusive: Relai raises $6.9M to enable verifiable and continuous learning for AI agents

NinjaOne Secures Over $400M in Fresh Funding for Cybersecurity Upgrade